Annual Drug Patent Expirations for MYDAYIS
Mydayis is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for MYDAYIS.
This drug has thirty-one patent family members in thirty countries.
The generic ingredient in MYDAYIS is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. One supplier is listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com